Toward an integrated pipeline for protein biomarker development
- PMID: 25218201
- DOI: 10.1016/j.bbapap.2014.09.006
Toward an integrated pipeline for protein biomarker development
Abstract
Protein biomarker development is a multidisciplinary task involving basic, translational and clinical research. Integration of multidisciplinary efforts in a single pipeline is challenging, but crucial to facilitate rational discovery of protein biomarkers and alleviate existing disappointments in the field. In this review, we discuss in detail individual phases of biomarker development pipeline, such as biomarker candidate identification, verification and validation. We focus on mass spectrometry as a principal technique for protein identification and quantification, and discuss complementary -omics approaches for selection of biomarker candidates. Proteomic samples, protein-based clinical laboratory tests and limitations of biomarker development are reviewed in detail, and critical assessment of all phases of biomarker development pipeline is provided. This article is part of a Special Issue entitled: Medical Proteomics.
Keywords: Biomarker discovery; Biomarker validation; Biomarker verification; Mass spectrometry; Protein biomarker; Proteomics.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Targeted mass spectrometry approaches for protein biomarker verification.J Proteomics. 2011 Nov 18;74(12):2650-9. doi: 10.1016/j.jprot.2011.04.011. Epub 2011 Apr 21. J Proteomics. 2011. PMID: 21540133 Review.
-
Mass spectrometry-based proteomic quest for diabetes biomarkers.Biochim Biophys Acta. 2015 Jun;1854(6):519-27. doi: 10.1016/j.bbapap.2014.12.012. Epub 2014 Dec 30. Biochim Biophys Acta. 2015. PMID: 25556002 Review.
-
Qualification and Verification of Protein Biomarker Candidates.Adv Exp Med Biol. 2016;919:493-514. doi: 10.1007/978-3-319-41448-5_23. Adv Exp Med Biol. 2016. PMID: 27975232 Review.
-
Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.J Neurochem. 2019 Nov;151(4):397-416. doi: 10.1111/jnc.14635. Epub 2019 Jan 31. J Neurochem. 2019. PMID: 30474862 Free PMC article. Review.
-
Targeted and Untargeted Proteomics Approaches in Biomarker Development.Proteomics. 2020 May;20(9):e1900029. doi: 10.1002/pmic.201900029. Epub 2020 Jan 30. Proteomics. 2020. PMID: 31729135 Review.
Cited by
-
Redefining serological diagnostics with immunoaffinity proteomics.Clin Proteomics. 2023 Oct 12;20(1):42. doi: 10.1186/s12014-023-09431-y. Clin Proteomics. 2023. PMID: 37821808 Free PMC article. Review.
-
Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer.Discov Oncol. 2023 May 10;14(1):65. doi: 10.1007/s12672-023-00674-7. Discov Oncol. 2023. PMID: 37160813 Free PMC article. Review.
-
Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis.Front Oncol. 2022 Aug 31;12:966981. doi: 10.3389/fonc.2022.966981. eCollection 2022. Front Oncol. 2022. PMID: 36119470 Free PMC article. Review.
-
Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics.Anal Chem. 2022 Sep 27;94(38):12990-12999. doi: 10.1021/acs.analchem.2c01325. Epub 2022 Sep 12. Anal Chem. 2022. PMID: 36095284 Free PMC article.
-
An LC-MS/MS method for protein detection based on a mass barcode and dual-target recognition strategy.RSC Adv. 2020 Apr 23;10(27):16094-16100. doi: 10.1039/d0ra01783c. eCollection 2020 Apr 21. RSC Adv. 2020. PMID: 35493641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
